Carlsen EA, Loft M, Loft A, Berthelsen AK, et al. Prospective phase II trial of prognostication by (68)Ga-NOTA-AE105 uPAR PET in patients with neuroendocrine neoplasms: Implications for uPAR targeted therapy. J Nucl Med 2022 Jan 20. pii: jnumed.121.263177. doi: 10.2967/jnumed.121.263177.
PMID: 35058319